MedTrace Logo

Endovascular Treatment of Acute Ischemic Stroke With Underlying Intracranial Artery Stenosis

NCT06260969 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 470

Last updated 2024-02-15

No results posted yet for this study

Summary

The study is a prospective multicentre registry study. Patients admitted to 10 stroke centres nationwide from September 2022 to September 2025 with acute ischaemic stroke due to large vessel occlusion considering underlying ICAS and treated with emergency endovascular thrombolysis were included for analysis. Patients who met the general inclusion criteria underwent thrombectomy and the necessary remedial treatment.

Conditions

  • Large Vessel Occlusion
  • Intracranial Artery Occlusion With Cerebral Infarction
  • Endovascular Treatments
  • Acute Ischemic Stroke

Interventions

DEVICE

balloon dilatation

Direct balloon dilation vs stenting vs embolectomy + tirofiban vs embolectomy + balloon dilation vs embolectomy + balloon dilation + intracranial stenting

Sponsors & Collaborators

  • Tianjin Huanhu Hospital

    lead OTHER

Principal Investigators

  • Ming Wei, doctorate · Tianjin Huanhu Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2025-09-30
Completion
2025-09-30
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06260969 on ClinicalTrials.gov